Walking into the out-patients’ department of Patan Hospital in Nepal recently, I saw the mother of a child enrolled into an enteric fever clinical trial a few years ago. She ...
In its recently published Mental health Gap Action Programme (mhGAP) operations manual, the World Health Organization stressed the enormous global disease burden that mental, neurological and substance use (MNS) conditions ...
This blog post was written by Alice Matimba, Vicky Nembaware, Faisal M. Fadlelmola, Fouzia Radouani, and Nicola Mulder Genomic medicine applies genomic information to disease risk prediction, progression, treatment efficacy ...
Three quarters of the global disease burden associated with mental, neurological and substance use (MNS) disorders occur in low- and middle-income countries (LMICs). Despite this high burden, a large treatment ...